Literature DB >> 30458187

Increase interval training intensity improves plasma volume variations and aerobic performances in response to intermittent exercise.

Fatma Rhibi1, Jacques Prioux2, Mossadok Ben Attia3, Anthony C Hackney4, Hassane Zouhal2, Abderraouf Ben Abderrahman5.   

Abstract

PURPOSE: We studied the effect of two interval training programs of varying intensities (100% vs. 110% of maximal aerobic velocity [MAV]) on hematocrit (Ht), hemoglobin (Hb), and plasma volume variations (PVV) in young men.
METHODS: Thirty-nine male volunteered were assigned to two control groups (CG100, n = 9 and CG110, n = 10), and two training groups (one with 100% MAV [EG100, n = 10] and one with 110% MAV [EG110, n = 10]). All participants performed a maximal graded exercise test and an intermittent exercise (IE) protocol. Blood was collected at rest, at the end of the IE and after 15 min of recovery, before and after 8-weeks-training. Interval training (IT) sessions consist of 30s IE run at 100% or 110% MAV with 30s recovery at 50% MAV.
RESULTS: After training, time to exhaustion (TTE) was improved in EG110 (+613.7) and EG100 (+397.5). This improvement was greater in EG110 than EG100 (p < 0.005). After training, Hb deceased in EG100 and EG110 at rest (p < 0.01), at the end of IE (p = 0.000) and after 15 min of recovery (p = 0.01). This decrease was more slightly more substantial at rest in EG100 (-0.6%) than EG110 (-0.3%). After training, Ht decreased in EG100 and EG110 at rest (p = 0.001), at the end of IE (p = 0.000) and at 15 min of recovery (p = 0.01). This decrease was more important in EG110 than EG100 at rest (-2.7%), at the end of IE (-2.1%) and after 15 min recovery. After training, PVVrest and PVVend increased in EG100 (+2.2%) and EG110 (+3.2%). No significant difference between EG100 and EG110 was observed.
CONCLUSION: Increasing IT intensity by 10% MAV increases PVVrest and PVVend. Despite the fact that EG100 and EG110 had the same PVVend after training, greater performances were recorded in EG110.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood viscosity; Endurance performance; Exercise intensity; Intermittent training

Mesh:

Year:  2018        PMID: 30458187     DOI: 10.1016/j.physbeh.2018.11.020

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  5 in total

1.  Effects of eight weeks of mat pilates training on selected hematological parameters and plasma volume variations in healthy active women.

Authors:  Nourhen Ghazel; Amine Souissi; Iyed Salhi; Ismail Dergaa; Hugo Cesar Martins-Costa; Sarah Musa; Helmi Ben Saad; Abderraouf Ben Abderrahman
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

2.  An efficient method for measuring plasma volume using indocyanine green dye.

Authors:  Sixtus Aguree; Alison D Gernand
Journal:  MethodsX       Date:  2019-05-08

3.  Benefits on Hematological and Biochemical Parameters of a High-Intensity Interval Training Program for a Half-Marathon in Recreational Middle-Aged Women Runners.

Authors:  Jèssica B Bonet; Casimiro Javierre; João Tiago Guimarães; Sandra Martins; David Rizo-Roca; Jorge Beleza; Ginés Viscor; Teresa Pagès; José Magalhães; Joan R Torrella
Journal:  Int J Environ Res Public Health       Date:  2022-01-03       Impact factor: 3.390

4.  Inflammatory cytokines and metabolic responses to high-intensity intermittent training: effect of the exercise intensity.

Authors:  Fatma Rhibi; Hassane Zouhal; Fabio Santos Lira; Nejmeddine Ouerghi; Jacques Prioux; Sophia Besbes; Jed M Tijani; Anthony C Hackney; Abderraouf Ben Abderrahman
Journal:  Biol Sport       Date:  2021-04-09       Impact factor: 2.806

5.  Effects of different training intensities in high-intensity interval training (HIIT) on maximal aerobic velocity, hematological and muscle-damage markers in healthy young adults.

Authors:  Urs Granacher; Hassane Zouhal; Fatma Rhibi; Abderraouf Ben Abderrahman; Jacques Prioux; Cain C T Clark; Benoît Bideau; Sophia Besbes; Anthony C Hackney
Journal:  BMC Sports Sci Med Rehabil       Date:  2022-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.